Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

As genomic technologies become more accessible, they have the potential to reduce healthcare disparities and improve equity in medical treatment.

A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University's Department of Neurology and Neurosurgery maps out the ...

The Australian government has released Cancer Australia's National Framework for Genomics in Cancer Control, marking a significant step toward ...

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the ...

DIGITAL has played a key role in driving genomics innovation, commercialization and adoption with an $83 million genomics portfolio spanning the health and natural resources sectors. DIGITAL's ...